Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
- Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
- Indonesia is seeking Halal Certification for the vaccine since no animal cells or products were used in the production of the vaccine.
- The pharmaceutical company is currently manufacturing Covid-19 primary series vaccine, while booster vaccine is in the clinical trial stage and soon followed by vaccine for children.
- Bio Farma became a holding company after a merger of three listed state-owned pharmaceutical companies in Indonesia.